BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20377778)

  • 1. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
    Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
    Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a chronic kidney disease clinic in achieving K/DOQI guideline targets at initiation of dialysis--a single-centre experience.
    Lee W; Campoy S; Smits G; Vu Tran Z; Chonchol M
    Nephrol Dial Transplant; 2007 Mar; 22(3):833-8. PubMed ID: 17127695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.
    Mau LW; Liu J; Qiu Y; Guo H; Ishani A; Arneson TJ; Gilbertson DT; Dunning SC; Collins AJ
    Am J Kidney Dis; 2010 Mar; 55(3):549-57. PubMed ID: 20116913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease management in chronic kidney disease.
    Rastogi A; Linden A; Nissenson AR
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Referral to nephrologists for chronic kidney disease care: is non-diabetic kidney disease ignored?
    Navaneethan SD; Nigwekar S; Sengodan M; Anand E; Kadam S; Jeevanantham V; Grieff M; Choudhry W
    Nephron Clin Pract; 2007; 106(3):c113-8. PubMed ID: 17522473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary CKD care enhances outcomes at dialysis initiation.
    Dixon J; Borden P; Kaneko TM; Schoolwerth AC
    Nephrol Nurs J; 2011; 38(2):165-71. PubMed ID: 21520695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain].
    Górriz JL; Sancho A; Pallardó LM; Amoedo ML; Martín M; Sanz P; Barril G; Selgas R; Salgueira M; Palma A; de la Torre M; Ferreras I
    Nefrologia; 2002; 22(1):49-59. PubMed ID: 11987685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.
    Nissenson AR; Agarwal R; Allon M; Cheung AK; Clark W; Depner T; Diaz-Buxo JA; Kjellstrand C; Kliger A; Martin KJ; Norris K; Ward R; Wish J
    Semin Dial; 2004; 17(5):380-97. PubMed ID: 15461748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience.
    Marrón B; Ortiz A; de Sequera P; Martín-Reyes G; de Arriba G; Lamas JM; Martínez Ocaña JC; Arrieta J; Martínez F;
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii51-5. PubMed ID: 16825262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting dialysis start at 6.0 ml/min/1.73 m2 eGFR--a study on safety, quality of life and economic impact.
    Di Micco L; Torraca S; Pota A; Di Giuseppe D; Pisani A; Spinelli L; De Portu S; Sabbatini M; Mantovani L; Cianciaruso B
    Nephrol Dial Transplant; 2009 Nov; 24(11):3434-40. PubMed ID: 19531671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of an ambulatory program devoted to chronic renal insufficiency on the reduction of mobidity and hospitalization among patients at the beginning of dialysis treatment].
    Malberti F; Ravani P
    G Ital Nefrol; 2003; 20(2):127-32. PubMed ID: 12746797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.
    Collins AJ
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 2():ii2-6. PubMed ID: 12819293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes.
    Curtis BM; Ravani P; Malberti F; Kennett F; Taylor PA; Djurdjev O; Levin A
    Nephrol Dial Transplant; 2005 Jan; 20(1):147-54. PubMed ID: 15585514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
    Cheung J; Yu A; LaBossiere J; Zhu Q; Fedorak RN
    Gastrointest Endosc; 2010 Jan; 71(1):44-9. PubMed ID: 19595311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
    Khan S
    Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.